1. Academic Validation
  2. Structural dissection of sequence recognition and catalytic mechanism of human LINE-1 endonuclease

Structural dissection of sequence recognition and catalytic mechanism of human LINE-1 endonuclease

  • Nucleic Acids Res. 2021 Nov 8;49(19):11350-11366. doi: 10.1093/nar/gkab826.
Ian Miller 1 Max Totrov 2 Lioubov Korotchkina 3 Denis N Kazyulkin 3 Andrei V Gudkov 3 4 Sergey Korolev 1
Affiliations

Affiliations

  • 1 Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA.
  • 2 Molsoft LLC, San Diego, CA 92121, USA.
  • 3 Genome Protection, Inc., Buffalo, NY 14203, USA.
  • 4 Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Abstract

Long interspersed nuclear element-1 (L1) is an autonomous non-LTR retrotransposon comprising ∼20% of the human genome. L1 self-propagation causes genomic instability and is strongly associated with aging, Cancer and Other Diseases. The Endonuclease domain of L1's ORFp2 protein (L1-EN) initiates de novo L1 integration by nicking the consensus sequence 5'-TTTTT/AA-3'. In contrast, related nucleases including structurally conserved apurinic/apyrimidinic Endonuclease 1 (APE1) are non-sequence specific. To investigate mechanisms underlying sequence recognition and catalysis by L1-EN, we solved crystal structures of L1-EN complexed with DNA substrates. This showed that conformational properties of the preferred sequence drive L1-EN's sequence-specificity and catalysis. Unlike APE1, L1-EN does not bend the DNA helix, but rather causes 'compression' near the cleavage site. This provides multiple advantages for L1-EN's role in retrotransposition including facilitating use of the nicked poly-T DNA strand as a primer for reverse transcription. We also observed two alternative conformations of the scissile bond phosphate, which allowed us to model distinct conformations for a nucleophilic attack and a transition state that are likely applicable to the entire family of nucleases. This work adds to our mechanistic understanding of L1-EN and related nucleases and should facilitate development of L1-EN inhibitors as potential Anticancer and antiaging therapeutics.

Figures